# Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

> **NCT00315640** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 70 (actual)

## Conditions studied

- Eye Diseases

## Interventions

- **DRUG:** Anecortave Acetate Sterile Suspension, 6 mg/mL
- **DRUG:** Anecortave Acetate Suspension Depot, 30 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 60 mg/mL
- **OTHER:** Anecortave Acetate Vehicle

## Key facts

- **NCT ID:** NCT00315640
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315640, "Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00315640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*